Vaginal Photobiomodulation for Chronic Pelvic Pain

This study is looking at whether a treatment called SoLa Pelvic Therapy can help women with chronic pelvic pain. This therapy uses a special laser that shines near-infrared light into the vaginal tissues. Researchers want to see if 8 treatments can reduce overall pelvic pain, and also pain during activities like standing, sitting, urinating, bowel movements, and intercourse. You might be able to join if you are a woman aged 18 or older, have had chronic pelvic pain for at least 3 months, and your pain level is 4 or higher. The study aims to enroll 126 participants. The current status of this study is unclear.

Study design
This is a multi-center, triple-masked randomized study comparing vaginal photobiomodulation to a sham treatment. It plans to include 126 participants, with 63 receiving the active treatment and 63 receiving the sham.
What's involved
You would undergo a screening gynecologic evaluation, provide informed consent, and then receive 8 treatments twice a week. Specific treatment time is calculated based on vaginal length.
Compensation
Not stated in the trial record.
Follow-up
Your overall pelvic pain will be measured at baseline, 1 week after completing treatment, and 3 months after completing treatment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06673108

Vaginal Photobiomodulation for Chronic Pelvic Pain

Completed
PHASE2Ages 18+InterventionalTreatment
SoLa Pelvic Therapy
~128 participants
Updated 2026-08-25 on ClinicalTrials.gov
What's tested:SoLa Pelvic TherapySham

At a glance

Recruiting sites
0 of 11 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Overall pelvic pain
Measured over At baseline, at 1-week after completing treatment, and at 3 months after completing treatment.
Chronic Pelvic Pain
Chronic Pelvic Pain Syndrome (CPPS)
11 sites across 9 states
California2
Massachusetts2
Alabama1
District of Columbia1
Kansas1
Minnesota1
Mississippi1
Tennessee1
  • Georgine Lamvu, MD, MPH · PRINCIPAL_INVESTIGATOR · SoLá Pelvic Therapy

This trial hasn't published a contact. View it on ClinicalTrials.gov

  • Overall pelvic painAt baseline, at 1-week after completing treatment, and at 3 months after completing treatment.

    Overall pelvic pain level as measured on a 0-10 numeric rating pain scale (NRPS). On this scale, 0 represents no pain and 10 represents wors pain possible. Pain will be analyzed as median pain levels and % of participants achieving a minimal clinically important difference (MCID) defined as reduction in pain level of 2 or more NRPS points.